Metabolic syndrome: epidemiology and its risks;Le syndrome métabolique : son épidémiologie et ses risques

Annales de Dermatologie et de Venereologie

Volumn 135, Issue SUPPL. 4, 2008, Pages 249-253

  Lameira, D ^a,b   Lejeune, S ^a,b   Mourad, J J ^a,b  

^a AVICENNE HOSPITAL   (France)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

Cardiovascular risk; Metabolic syndrome; Obesity; Sedentarity

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; EDUCATION PROGRAM; FRANCE; HYPERTENSION; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NORTH AMERICA; OBESITY; PREVALENCE; CARDIOVASCULAR DISEASE; DEVELOPED COUNTRY; FEMALE; HUMAN; INCIDENCE; LIFESTYLE; MALE; PATIENT EDUCATION; RISK FACTOR; SKIN DISEASE; STATISTICS;

CARDIOVASCULAR DISEASES; DEVELOPED COUNTRIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; LIFE STYLE; MALE; METABOLIC SYNDROME X; OBESITY; PATIENT EDUCATION AS TOPIC; PREVALENCE; RISK FACTORS; SKIN DISEASES;

EID: 48849103629     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(08)70543-X     Document Type: Article

References (34)

1. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults. Finding from the third national health and nutrition examination survey. JAMA 287 (2002) 356-359
2. Bataille V., Perret B., Dallongeville J., Arveiler D., Yarnell J., Ducimetière P., et al. Metabolic syndrome and coronary heart disease risk in a population-based study of middle-aged men from France and Northern Ireland. A nested case-control study from the PRIME cohort. Diabetes Metab 32 5Pt 1 (2006) 475-479
3. Dallongeville J., Cottel D., Arveiler D., Tauber J.P., Bingham A., Wagner A., et al. The association of metabolic disorders with the metabolic syndrome is different in men and women. Ann Nutr Metab 48 (2004) 43-50
4. Bauduceau B., Baigts F., Bordier L., Burnat P., Ceppa F., Dumenil V., et al. Epidemiology of the metabolic syndrome in 2045 French military personnel (EPIMIL study). Diabetes Metab 31 4Pt 1 (2005) 353-359
5. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
6. Vague J. The degree of masculine differentiation of obesities. A factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Am J Clin Nutr 4 (1956) 20-34
7. National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the national cholesterol education program expert panel on detection evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
8. Alberti K.G., Zimmet P., Shaw J., and IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 366 (2005) 1059-1062
9. Chowdhury B., Lantz H., and Sjostrom L. Computed tomography-determined body composition in relation to cardiovascular risk factors in Indian and matched Swedish males. Metabolism 45 (1996) 634-644
10. Moebus S., Hanisch J.U., Aidelsburger P., Bramlage P., Wasem J., and Jöckel K.H. Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol 6 22 (2007) Epub
11. Zimmet P., Alberti K.G., Kaufman F., Tajima N., Silink M., Arslanian S., et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 8 (2007) 299-306
12. Hu G., Qiao Q., Tuomilehto J., Balkau B., Borch-Johnsen K., Pyorala K., and DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164 (2004) 1066-1076
13. Cameron A.J., Shaw J.E., and Zimmet P.Z. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 33 (2004) 351-375
14. Gami A.S., Witt B.J., Howard D.E., Erwin P.J., Gami L.A., Somers V.K., et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49 (2007) 403-414
15. Dekker J.M., Girman C., Rhodes T., Nijpels G., Stehouwer C.D., Bouter L.M., et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 112 (2005) 666-673
16. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
17. Guize L., Thomas F., Pannier B., Bean K., Jego B., and Benetos A. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions. Diabetes Care 30 (2007) 2381-2387
18. Ninomiya J.K., L'Italien G., Criqui M.H., WHyte J.L., Gamst A., and Chen R.S. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 109 (2004) 42-46
19. Wannamethee S.G., Shaper A.G., Lennon L., and Morris R.W. Metabolic syndrome versus Framingham Risk Score for prediction of coronary heart disease, stroke and type 2 diabetes mellitus. Arch Intern Med 165 (2005) 2644-2650
20. Stern M.P., Williams K., Gonzalez-Villalpando C., Hunt K.J., and Haffner S.M. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?. Diabetes Care 27 (2004) 2676-2681
21. McNeill A.M., Rosamond W.D., Girman C.J., Golden S.H., Schmidt M.I., East H.E., et al. The metabolic syndrome and 11 year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities study. Diabetes Care 28 (2005) 385-390
22. Navarro J., Redón J., Cea-Calvo L., Lozano J.V., Fernández-Pérez C., Bonet A., et al. Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study. Blood Press 16 (2007) 20-27
23. Schillaci G., Pirro M., Vaudo G., Gemelli F., Marchesi S., Porcellati C., et al. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 19 43 (2004) 1817-1822
24. Rantala A.O., Kauma H., Lilja M., Savolainen M.J., Reunanen A., and Kesäniemi Y.A. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med 245 (1999) 163-174
25. Cuspidi C., Meani S., Fusi V., Severgnini B., Valerio C., Catini E., et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 22 (2004) 1991-1998
26. Mulè G., Nardi E., Cottone S., Cusimano P., Volpe V., Piazza G., et al. Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 257 (2005) 503-513
27. Grandi A.M., Maresca A.M., Giudici E., Laurita E., Marchesi C., Solbiati F., et al. Metabolic syndrome and morphofunctional characteristics of the left ventricle in clinically hypertensive nondiabetic subjects. Am J Hypertens 19 (2006) 199-205
28. Protogerou A.D., Blacher J., Mavrikakis M., Lekakis J., and Safar M.E. Increased pulse pressure amplification in treated hypertensive subjects with metabolic syndrome. Am J Hypertens 20 (2007) 127-133
29. de Simone G., Olsen M.H., Wachtell K., Hille D.A., Dahlöf B., Ibsen H., et al. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage:the LIFE study. J Hum Hypertens 21 (2007) 625-632
30. Cull C.A., Jensen C.C., Retnakaran R., and Holman R.R. Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78. Circulation 116 (2007) 2119-2126
31. Sone H., Mizuno S., Fujii H., Yoshimura Y., Yamasaki Y., Ishibashi S., et al. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care 28 (2005) 1463-1471
32. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for Diabetes. Diabetologia 48 (2005) 1684-1699
33. Hanley A.J., Karter A.J., Williams K., Festa A., D'Agostino Jr. R.B., Wagenknecht L.E., et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation 112 (2005) 3713-3721
34. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D.S., Haffner S.M., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419